The future of cervical cancer prevention: human papillomavirus vaccines.
Human papillomavirus is recognised as the main cause of cervical cancer. Vaccines to protect against specific HPV types have been developed and a national HPV vaccination programme is due to begin in the UK in September 2008. Girls aged 12 to 13 years of age will be offered one of the vaccines, Cervarix, and it is hoped that it will offer them protection against over 70% of cervical cancer.
Cadman
Louise
L
Cancer Research UK, Centre for Epidemiology Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London.